Biocon Biologics Uk Plc
Clinical trials sponsored by Biocon Biologics Uk Plc, explained in plain language.
A subsidiary of Biocon, an Indian biopharmaceutical company.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New biosimilar aims to match opdivo for melanoma
Disease control Not yet recruitingThis study tests whether a new drug called Bmab1700 works the same as the approved immunotherapy Opdivo in people with melanoma who have had their tumors surgically removed. The trial will involve 120 adults with stage IIB to IV melanoma. Researchers will compare how the drugs mo…
Phase: PHASE1 • Sponsor: Biocon Biologics UK PLC • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New keytruda copycat tested in melanoma patients after surgery
Disease control Not yet recruitingThis study tests a new drug called Bmab1800 to see if it works like the approved drug Keytruda in people with stage IIB, IIC, or III melanoma after their tumor has been removed by surgery. About 138 adults will get either Bmab1800 or Keytruda, and researchers will compare how the…
Phase: PHASE1 • Sponsor: Biocon Biologics UK PLC • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC